Related references
Note: Only part of the references are listed.Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) as a Pathogenic Factor in Transient Focal Cerebral Ischemia
Bhakta Prasad Gaire et al.
MOLECULAR NEUROBIOLOGY (2018)
Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain
Hiroshi Ueda et al.
PAIN (2018)
Identifying lysophosphatidic acid receptor subtype 1 (LPA1) as a novel factor to modulate microglial activation and their TNF-α production by activating ERK1/2
Jin Hyun Kwon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2018)
Sphingosine 1-phosphate receptor subtype 3 (S1P3) contributes to brain injury after transient focal cerebral ischemia via modulating microglial activation and their M1 polarization
Bhakta Prasad Gaire et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype
I. Plastira et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Microglia activation and phagocytosis: relationship with aging and cognitive impairment in the rhesus monkey
Eli Shobin et al.
GEROSCIENCE (2017)
Microglial M1/M2 polarization and metabolic states
Ruben Orihuela et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
1-Oleyl-lysophosphatidic acid (LPA) promotes polarization of BV-2 and primary murine microglia towards an M1-like phenotype
Ioanna Plastira et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Promising Pharmacological Directions in the World of Lysophosphatidic Acid Signaling
Nicole C. Stoddard et al.
BIOMOLECULES & THERAPEUTICS (2015)
Inflammatory Responses in Brain Ischemia
Masahito Kawabori et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury
Eva Santos-Nogueira et al.
JOURNAL OF NEUROSCIENCE (2015)
Exogenous S1P Exposure Potentiates Ischemic Stroke Damage That Is Reduced Possibly by Inhibiting S1P Receptor Signaling
Eunjung Moon et al.
MEDIATORS OF INFLAMMATION (2015)
NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review
Ruey-Horng Shih et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2015)
Neuroprotective Effect of 6-Paradol in Focal Cerebral Ischemia Involves the Attenuation of Neuroinflammatory Responses in Activated Microglia
Bhakta Prasad Gaire et al.
PLOS ONE (2015)
Thematic Review Series: Lysophospholipids and their Receptors LPA receptor signaling: pharmacology, physiology, and pathophysiology
Yun C. Yung et al.
JOURNAL OF LIPID RESEARCH (2014)
Lysophospholipids and their receptors in the central nervous system
Ji Woong Choi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro
Vibol Chhor et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Microglial Responses after Ischemic Stroke and Intracerebral Hemorrhage
Roslyn A. Taylor et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation
Norihiko Sakai et al.
FASEB JOURNAL (2013)
Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi
LiZe Gu et al.
JOURNAL OF NEUROINFLAMMATION (2013)
INVOLVEMENT OF LPA1 RECEPTOR SIGNALING IN CEREBRAL ISCHEMIA-INDUCED NEUROPATHIC PAIN
S. K. Halder et al.
NEUROSCIENCE (2013)
The TSC-mTOR pathway regulates macrophage polarization
Vanessa Byles et al.
NATURE COMMUNICATIONS (2013)
An Automated Method to Quantify Microglia Morphology and Application to Monitor Activation State Longitudinally In Vivo
Cleopatra Kozlowski et al.
PLOS ONE (2012)
Amelioration of Dermal Fibrosis by Genetic Deletion or Pharmacologic Antagonism of Lysophosphatidic Acid Receptor 1 in a Mouse Model of Scleroderma
Flavia V. Castelino et al.
ARTHRITIS AND RHEUMATISM (2011)
NF-kappa B and innate immunity in ischemic stroke
Olivier A. Harari et al.
INNATE INFLAMMATION AND STROKE (2010)
Lysophosphatidic Acid Level and the Incidence of Silent Brain Infarction in Patients with Nonvalvular Atrial Fibrillation
Zhen-Guang Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells
Rong Jin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain
Lin Ma et al.
JOURNAL OF NEUROCHEMISTRY (2010)
The Science of Stroke: Mechanisms in Search of Treatments
Michael A. Moskowitz et al.
NEURON (2010)
Microglial Activation in Stroke: Therapeutic Targets
Midori A. Yenari et al.
NEUROTHERAPEUTICS (2010)
Microglial Activation and Chronic Neurodegeneration
Melinda E. Lull et al.
NEUROTHERAPEUTICS (2010)
Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture
Eva Bernhart et al.
PROTEOMICS (2010)
NCX1 Expression and Functional Activity Increase in Microglia Invading the Infarct Core
Francesca Boscia et al.
STROKE (2009)
The Role of Lysophosphatidic Acid Receptor (LPA1) in the Oxygen-Induced Retinal Ganglion Cell Degeneration
Chun Yang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications
T. Weichhart et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Lysophosphatidic acid stimulates astrocyte proliferation through LPA(1)
Shinya Shano et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Michelle L. Block et al.
NATURE REVIEWS NEUROSCIENCE (2007)
p38 mitogen-activated protein kinase controls NF-kappa B transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens
Chris M. Olson et al.
INFECTION AND IMMUNITY (2007)
Loss of spinal substance P pain transmission under the condition of LPAI receptor-mediated neuropathic pain
Makoto Inoue et al.
MOLECULAR PAIN (2006)
MAPK signalling pathways as molecular targets for anti-inflammatory therapy - from molecular mechanisms to therapeutic benefits
B Kaminska
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Temporal control of NF-κB activation by ERK differentially regulates interleukin-1β-induced gene expression
BB Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Long-term prognosis of ischemic stroke in young adults - Study of 272 cases
JF Varona et al.
JOURNAL OF NEUROLOGY (2004)
Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling
M Inoue et al.
NATURE MEDICINE (2004)
Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice
M Schilling et al.
EXPERIMENTAL NEUROLOGY (2003)
Persistent activation of nuclear factor-κB by interleukin-1β and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase
BB Jiang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain
D Ito et al.
STROKE (2001)
NF-κB in neuronal plasticity and neurodegenerative disorders
MP Mattson et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)